These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2005324)

  • 1. The effect of dapsone in steroid-dependent asthma.
    Berlow BA; Liebhaber MI; Dyer Z; Spiegel TM
    J Allergy Clin Immunol; 1991 Mar; 87(3):710-5. PubMed ID: 2005324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin for steroid-dependent asthma.
    Szczeklik A; Nizankowska E; Dworski R; Domagala B; Pinis G
    Allergy; 1991 May; 46(4):312-5. PubMed ID: 1897692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of methotrexate in the management of steroid-dependent asthma.
    Coffey MJ; Sanders G; Eschenbacher WL; Tsien A; Ramesh S; Weber RW; Toews GB; McCune WJ
    Chest; 1994 Jan; 105(1):117-21. PubMed ID: 7903921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of maintenance theophylline in steroid-dependent asthma.
    Nassif EG; Weinberger M; Thompson R; Huntley W
    N Engl J Med; 1981 Jan; 304(2):71-5. PubMed ID: 7003383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of inhaled beclomethasone dipropionate 1000 micrograms twice daily and oral prednisone 10 mg once daily in asthmatic patients.
    Bosman HG; van Uffelen R; Tamminga JJ; Paanakker LR
    Thorax; 1994 Jan; 49(1):37-40. PubMed ID: 8153939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations.
    Belda J; Margarit G; Martínez C; Bellido-Casado J; Casan P; Torrejón M; Brufal M; Rodríguez-Jerez F; Sanchis J
    Eur Respir J; 2007 Dec; 30(6):1143-9. PubMed ID: 17690122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
    Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
    Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
    J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice.
    Lim S; Jatakanon A; Gordon D; Macdonald C; Chung KF; Barnes PJ
    Thorax; 2000 Oct; 55(10):837-41. PubMed ID: 10992535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study of auranofin in the treatment of steroid-dependent asthma.
    Bernstein DI; Bernstein IL; Bodenheimer SS; Pietrusko RG
    J Allergy Clin Immunol; 1988 Jan; 81(1):6-16. PubMed ID: 3276761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in the treatment of steroid-dependent asthma.
    Dyer PD; Vaughan TR; Weber RW
    J Allergy Clin Immunol; 1991 Aug; 88(2):208-12. PubMed ID: 1880321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin in the treatment of steroid dependent asthma: a double blind study.
    Nierop G; Gijzel WP; Bel EH; Zwinderman AH; Dijkman JH
    Thorax; 1992 May; 47(5):349-54. PubMed ID: 1609377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone as an oral corticosteroid sparing agent for asthma.
    Dewey A; Bara A; Dean T; Walters H
    Cochrane Database Syst Rev; 2002; (4):CD003268. PubMed ID: 12519591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma.
    Ogirala RG; Aldrich TK; Prezant DJ; Sinnett MJ; Enden JB; Williams MH
    N Engl J Med; 1991 Feb; 324(9):585-9. PubMed ID: 2021388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients.
    Lacronique J; Renon D; Georges D; Henry-Amar M; Marsac J
    Eur Respir J; 1991 Jul; 4(7):807-12. PubMed ID: 1955002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
    Heaphy MR; Albrecht J; Werth VP
    Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline treatment results in reduced oral steroid requirements in adult asthma.
    Daoud A; Gloria CJ; Taningco G; Hammerschlag MR; Weiss S; Gelling M; Roblin PM; Joks R
    Allergy Asthma Proc; 2008; 29(3):286-94. PubMed ID: 18534087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate in the treatment of asthma. Open trial in 10 corticoid-dependent patients with severe asthma].
    Becquart LA; Wallaert B; Lassalle P; Guéné-Ribassin C; Tonnel AB
    Rev Mal Respir; 1994; 11(6):565-71. PubMed ID: 7831506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary estimation of results of high-dose intravenous immunoglobulin in severe steroid-dependent adult asthma].
    Kłos K; Kruszewski J
    Pol Merkur Lekarski; 2001 Nov; 11(65):379-83. PubMed ID: 11852803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.